KARDNASDAQ

Kardigan, Inc.

Yahoo Finance

Loading price data…

Recent & upcoming events

Past events

Sep 16

Lock-up Time TBD

IPO lock-up expiry (est., 90d)

Add to Google Calendar

Dec 30

Est.

IPO 7:00

New listing (scheduled)

Add to Google Calendar

Past events

Sep 16

Lock-up Time TBD

IPO lock-up expiry (est., 90d)

Add to Google Calendar

Is this information incorrect?

Data provided by Twelve Data

Save to calendar

Company info

Kardigan Inc. is a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company works on targeted therapies designed to address the underlying disease mechanisms behind specific heart conditions, including cardiomyopathies that can lead to heart failure. Its current pipeline centers on clinical-stage cardiovascular programs aimed at diseases where approved treatment options remain limited or unavailable. Kardigan also uses a research and translational platform that combines clinical data, analytics, and precision medicine approaches to support drug discovery and development. The company operates as a single segment business centered on cardiovascular therapeutics and serves the broader healthcare and biotechnology market. Kardigan Inc. is headquartered in Princeton, New Jersey, and maintains its operational base in South San Francisco, California.

Ticker KARD

Industry Pharmaceutical Preparations

Sector Health Care

Privacy Policy Terms of Service Commercial Transactions Disclosure Billing & Cancellation Advertising Policy Licenses Status 日本語

Kardigan, Inc.

Share screenshot

Recent & upcoming events